View Item 

Show simple item record

Testâ retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trial
dc.contributor.authorNewitt, David C.
dc.contributor.authorZhang, Zheng
dc.contributor.authorGibbs, Jessica E.
dc.contributor.authorPartridge, Savannah C.
dc.contributor.authorChenevert, Thomas L.
dc.contributor.authorRosen, Mark A.
dc.contributor.authorBolan, Patrick J.
dc.contributor.authorMarques, Helga S.
dc.contributor.authorAliu, Sheye
dc.contributor.authorLi, Wen
dc.contributor.authorCimino, Lisa
dc.contributor.authorJoe, Bonnie N.
dc.contributor.authorUmphrey, Heidi
dc.contributor.authorOjeda‐fournier, Haydee
dc.contributor.authorDogan, Basak
dc.contributor.authorOh, Karen
dc.contributor.authorAbe, Hiroyuki
dc.contributor.authorDrukteinis, Jennifer
dc.contributor.authorEsserman, Laura J.
dc.contributor.authorHylton, Nola M.
dc.date.accessioned2019-05-31T18:27:54Z
dc.date.availableWITHHELD_14_MONTHS
dc.date.available2019-05-31T18:27:54Z
dc.date.issued2019-06
dc.identifier.citationNewitt, David C.; Zhang, Zheng; Gibbs, Jessica E.; Partridge, Savannah C.; Chenevert, Thomas L.; Rosen, Mark A.; Bolan, Patrick J.; Marques, Helga S.; Aliu, Sheye; Li, Wen; Cimino, Lisa; Joe, Bonnie N.; Umphrey, Heidi; Ojeda‐fournier, Haydee ; Dogan, Basak; Oh, Karen; Abe, Hiroyuki; Drukteinis, Jennifer; Esserman, Laura J.; Hylton, Nola M. (2019). "Testâ retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trial." Journal of Magnetic Resonance Imaging 49(6): 1617-1628.
dc.identifier.issn1053-1807
dc.identifier.issn1522-2586
dc.identifier.urihttps://hdl.handle.net/2027.42/149339
dc.publisherWiley Periodicals, Inc.
dc.subject.otherbreast MRI
dc.subject.otherdiffusion
dc.subject.otherreproducibility
dc.subject.othertreatment response
dc.subject.otherbreast cancer
dc.titleTestâ retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trial
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMedicine (General)
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/149339/1/jmri26539.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/149339/2/jmri26539_am.pdf
dc.identifier.doi10.1002/jmri.26539
dc.identifier.sourceJournal of Magnetic Resonance Imaging
dc.identifier.citedreferenceAliu SO, Newitt DC, Li W, et al. Quality assessment and ranking system for quantitative breast diffusionâ weighted imaging of the breast in the ACRIN 6698 trial. In: Proc 23rd Annual Meeting ISMRM, Toronto; 2015 (abstract 1311).
dc.identifier.citedreferencePartridge SC, Zheng Z, Newitt DC, et al. Diffusionâ weighted MRI predicts pathologic response in neoadjuvant treatment of breast cancer: The ACRIN 6698 Multicenter Trial. Radiology 2018 [Epub ahead of print].
dc.identifier.citedreferenceGalban CJ, Ma B, Malyarenko D, et al. Multiâ site clinical evaluation of DWâ MRI as a treatment response metric for breast cancer patients undergoing neoadjuvant chemotherapy. PLoS One 2015; 10: e0122151.
dc.identifier.citedreferenceLi XR, Cheng LQ, Liu M, et al. DWâ MRI ADC values can predict treatment response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. Med Oncol 2012; 29: 425 â 431.
dc.identifier.citedreferenceSharma U, Danishad KK, Seenu V, Jagannathan NR. Longitudinal study of the assessment by MRI and diffusionâ weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. NMR Biomed 2009; 22: 104 â 113.
dc.identifier.citedreferenceManton DJ, Chaturvedi A, Hubbard A, et al. Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy. Br J Cancer 2006; 94: 427 â 435.
dc.identifier.citedreferenceNilsen L, Fangberget A, Geier O, Olsen DR, Seierstad T. Diffusionâ weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. Acta Oncol 2010; 49: 354 â 360.
dc.identifier.citedreferenceThakur SB, Durando M, Milans S, et al. Apparent diffusion coefficient in estrogen receptorâ positive and lymph nodeâ negative invasive breast cancers at 3.0T DWâ MRI: A potential predictor for an oncotype Dx test recurrence score. J Magn Reson Imaging 2018; 47: 401 â 409.
dc.identifier.citedreferenceBufi E, Belli P, Costantini M, et al. Role of the apparent diffusion coefficient in the prediction of response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. Clin Breast Cancer 2015; 15: 370 â 380.
dc.identifier.citedreferenceLiu S, Ren R, Chen Z, et al. Diffusionâ weighted imaging in assessing pathological response of tumor in breast cancer subtype to neoadjuvant chemotherapy. J Magn Reson Imaging 2015; 42: 779 â 787.
dc.identifier.citedreferenceRichard R, Thomassin I, Chapellier M, et al. Diffusionâ weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. Eur Radiol 2013; 23: 2420 â 2431.
dc.identifier.citedreferenceChenevert TL, Stegman LD, Taylor JM, et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 2000; 92: 2029 â 2036.
dc.identifier.citedreferenceAliu SO, Jones EF, Azziz A, et al. Repeatability of quantitative MRI measurements in normal breast tissue. Transl Oncol 2014; 7: 130 â 137.
dc.identifier.citedreferenceGiannotti E, Waugh S, Priba L, Davis Z, Crowe E, Vinnicombe S. Assessment and quantification of sources of variability in breast apparent diffusion coefficient (ADC) measurements at diffusion weighted imaging. Eur J Radiol 2015; 84: 1729 â 1736.
dc.identifier.citedreferenceJang M, Kim SM, Yun BL, et al. Reproducibility of apparent diffusion coefficient measurements in malignant breast masses. J Korean Med Sci 2015; 30: 1689 â 1697.
dc.identifier.citedreferenceO’Flynn EA, Morgan VA, Giles SL, deSouza NM. Diffusion weighted imaging of the normal breast: reproducibility of apparent diffusion coefficient measurements and variation with menstrual cycle and menopausal status. Eur Radiol 2012; 22: 1512 â 1518.
dc.identifier.citedreferencePartridge SC, Murthy RS, Ziadloo A, White SW, Allison KH, Lehman CD. Diffusion tensor magnetic resonance imaging of the normal breast. Magn Reson Imaging 2010; 28: 320 â 328.
dc.identifier.citedreferencePetralia G, Bonello L, Summers P, et al. Intraobserver and interobserver variability in the calculation of apparent diffusion coefficient (ADC) from diffusionâ weighted magnetic resonance imaging (DWâ MRI) of breast tumours. Radiol Med 2011; 116: 466 â 476.
dc.identifier.citedreferenceSpick C, Bickel H, Pinker K, et al. Diffusionâ weighted MRI of breast lesions: a prospective clinical investigation of the quantitative imaging biomarker characteristics of reproducibility, repeatability, and diagnostic accuracy. NMR Biomed 2016; 29: 1445 â 1453.
dc.identifier.citedreferenceClauser P, Marcon M, Maieron M, Zuiani C, Bazzocchi M, Baltzer PA. Is there a systematic bias of apparent diffusion coefficient (ADC) measurements of the breast if measured on different workstations? An interâ and intraâ reader agreement study. Eur Radiol 2016; 26: 2291 â 2296.
dc.identifier.citedreference2017 QIBA Profile for DWI http://qibawiki.rsna.org/images/1/1d/QIBADWIProfilev1.45_20170427_v5_accepted.pdf Last accessed July 18, 2018.
dc.identifier.citedreferenceACRINâ 6698: Diffusion weighted MR imaging biomarkers for assessment of breast cancer response to neoadjuvant treatment: A subâ study of the Iâ SPY 2 TRIAL. http://www.acrin.org/Portals/0/Protocols/6698/Protocol-ACRIN6698_v2.29.12_active_ForOnline.pdf Last accessed February 2, 2018.
dc.identifier.citedreferenceBarker AD, Sigman CC, Kelloff GJ, Hylton NM, Berry DA, Esserman LJ. Iâ SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy. Clin Pharmacol Ther 2009; 86: 97 â 100.
dc.identifier.citedreferenceChenevert TL, Galban CJ, Ivancevic MK, et al. Diffusion coefficient measurement using a temperatureâ controlled fluid for quality control in multicenter studies. J Magn Reson Imaging 2011; 34: 983 â 987.
dc.identifier.citedreferenceIâ SPY 2: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer. https://clinicaltrials.gov/ct2/show/NCT01042379 Last accessed February 2, 2018.
dc.identifier.citedreferenceStejskal EO, Tanner JE. Spin diffusion measurements: Spin echoes in the presence of a timeâ dependent field gradient. J Chem Phys 1965; 42: 288 â 292.
dc.identifier.citedreferenceDice LR. Measures of the amount of ecologic association between species. Ecology 1945; 26: 297 â 302.
dc.identifier.citedreferenceQuan H, Shih WJ. Assessing reproducibility by the withinâ subject coefficient of variation with random effects models. Biometrics 1996; 52: 1195 â 1203.
dc.identifier.citedreferenceBarnhart HX, Haber MJ, Lin LI. An overview on assessing agreement with continuous measurements. J Biopharm Stat 2007; 17: 529 â 569.
dc.identifier.citedreferenceZhang Z, Wang Y, Duan F. An AUCâ like index for agreement assessment. J Biopharm Stat 2014; 24: 893 â 907.
dc.identifier.citedreferenceBarnhart HX, Barboriak DP. Applications of the repeatability of quantitative imaging biomarkers: a review of statistical analysis of repeat data sets. Transl Oncol 2009; 2: 231 â 235.
dc.identifier.citedreferenceNewitt DC, Aliu SO, Witcomb N, et al. Realâ Time measurement of functional tumor volume by MRI to assess treatment response in breast cancer neoadjuvant clinical trials: Validation of the Aegis SER software platform. Transl Oncol 2014; 7: 94 â 100.
dc.identifier.citedreferencePartridge SC, Nissan N, Rahbar H, Kitsch AE, Sigmund EE. Diffusionâ weighted breast MRI: Clinical applications and emerging techniques. J Magn Reson Imaging 2017; 45: 337 â 355.
dc.identifier.citedreferenceMalyarenko D, Galban CJ, Londy FJ, et al. Multiâ system repeatability and reproducibility of apparent diffusion coefficient measurement using an iceâ water phantom. J Magn Reson Imaging 2013; 37: 1238 â 1246.
dc.identifier.citedreferenceSorace AG, Wu C, Barnes SL, et al. Repeatability, reproducibility, and accuracy of quantitative mri of the breast in the community radiology setting. J Magn Reson Imaging 2018 [Epub ahead of print].
dc.identifier.citedreferenceIacconi C, Giannelli M, Marini C, et al. The role of mean diffusivity (MD) as a predictive index of the response to chemotherapy in locally advanced breast cancer: a preliminary study. Eur Radiol 2010; 20: 303 â 308.
dc.identifier.citedreferenceBickel H, Pinker K, Polanec S, et al. Diffusionâ weighted imaging of breast lesions: Regionâ ofâ interest placement and different ADC parameters influence apparent diffusion coefficient values. Eur Radiol 2017; 27: 1883 â 1892.
dc.identifier.citedreferenceNewitt DC, Malyarenko D, Chenevert TL, et al. Multiâ site concordance of DWI metrics: Results of the NCI Quantitative Imaging Network ADC Mapping Collaborative Project. Int Soc Magn Reson Med 2017.
dc.identifier.citedreferenceHylton NM, Blume JD, Bernreuter WK, et al. Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapyâ results from ACRIN 6657/Iâ SPY TRIAL. Radiology 2012; 263: 663 â 672.
dc.identifier.citedreferenceHylton NM, Gatsonis CA, Rosen MA, et al. Neoadjuvant chemotherapy for breast cancer: functional tumor volume by MR imaging predicts recurrenceâ free survivalâ results from the ACRIN 6657/CALGB 150007 Iâ SPY 1 TRIAL. Radiology 2016; 279: 44 â 55.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jmri26539.pdf
Size:
4.992MB
Format:
PDF
View/Open
Name:
jmri26539_am.pdf
Size:
345.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.